|   Register      Thursday, March 11, 2010
space space space
spacer spacer spacer
spacer
UVG_VideoList
Recent Video
spacer
spacer spacer spacer
spacer spacer spacer
spacer
Text/HTML
 
Edward Cline, DPM, FACFAS

Edward Cline, DPM, FACFAS
Podiatrist


For appointments
call (573) 629-3500
Hannibal Regional Medical Building
6500 Hospital Drive
Hannibal, MO  63401

 

 
Edward Cline, DPM, FACFAS

Edward Cline, DPM, FACFAS
Podiatrist


For appointments
call (573) 629-3500
Hannibal Regional Medical Building
6500 Hospital Drive
Hannibal, MO  63401

 

spacer
spacer spacer spacer
spacer spacer spacer
spacer
Skin Grafting

At Hannibal Regional Medical Group we don't just talk about offer innovative world class solutions in health care.  One of those solutions is skin grafting using Dermagraft®, the leader in skin graft technology.

Check out the Dermagraft Patient Guide - Click Here!

At Hannibal Regional Medical Group we don't just talk about offer innovative world class solutions in health care.  One of those solutions is skin grafting using Dermagraft®, the leader in skin graft technology.

Check out the Dermagraft Patient Guide - Click Here!

spacer
spacer spacer spacer
spacer spacer spacer
spacer
Enter Title
 Dermagraft  

Dermagraft® is a cryopreserved human fibroblast-derived dermal substitute; it is composed of fibroblasts, extracellular matrix, and a bioabsorbable scaffold. 


 

Dermagraft is manufactured from human fibroblast cells derived from newborn foreskin tissue. During the manufacturing process, the human fibroblasts are seeded onto a bioabsorbable polyglactin mesh scaffold. The fibroblasts proliferate to fill the interstices of this scaffold and secrete human dermal collagen, matrix proteins, growth factors, and cytokines to create a three-dimensional human dermal substitute containing metabolically active, living cells. 


 

Dermagraft does not contain macrophages, lymphocytes, blood vessels, or hair follicles. 


 

Dermagraft is indicated for use in the treatment of full-thickness diabetic foot ulcers greater than 6 weeks duration, which extend through the dermis, but without tendon, muscle, joint capsule, or bone exposure. Dermagraft should be used in conjunction with standard wound care regimens and in patients who have adequate blood supply to the involved foot. Dermagraft is supplied frozen in a clear bag containing one piece of approximately 2” x 3” for a single-use application. 


 

Dermagraft Overview

•  Description Human fibroblast-derived dermal substitute


 

• Composition Composed of human fibroblasts, extracellular matrix, and bioabsorbable scaffold; does not contain macrophages, lymphocytes, blood vessels, or hair follicles


• Cultured In vitro

 


 

• Mode of Action Re-epithelialization—assists in the restoration of the dermal bed, allowing wounds to heal (when implanted into adequately prepared diabetic foot ulcers)


 

•  Primary Indication For use in the treatment of full-thickness diabetic foot ulcers


 

• Product Number 11045


 

 

Dermagraft® is manufactured by Advanced BioHealing, of La Jolla, CA.
Dermagraft is a registered trademark of Advanced BioHealing, Inc.
Caution: Federal [US] law restricts this device to sale by or on the order of a physician or properly licensed practitioner.


®2007 Advanced BioHealing, Inc. All Rights Reserved. DG-1007-01 6/07 Advanced BioHealing Inc. 10933 N. Torrey Pines Rod., Suite 200, La Jolla, CA 92037 www.AdvancedBioHealing.com

spacer
spacer spacer spacer
Copyright 2010 by Hannibal Regional Medical Group
Privacy Statement Terms Of Use